Molsidomin Heumann (Molsidomine)

Molsidomine, the active ingredient in Molsidomin Heumann, is a nitric oxide donor presented as a tablet for oral use. It is indicated for the management of angina pectoris and chronic stable angina in adult patients, helping to reduce myocardial oxygen demand.

GNH USA supplies Molsidomin Heumann as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, ensuring quality and regulatory compliance across markets. The product conforms to EU standards and is manufactured under GMP conditions and is available for bulk and individual orders.

Molsidomine is used in the cardiovascular system to manage angina‑related conditions.

Angina pectoris: reduces the frequency and severity of chest pain episodes by improving coronary blood flow. Chronic stable angina: decreases myocardial oxygen demand and enhances exercise tolerance. Ischemic heart disease: provides symptomatic relief in patients with stable ischemic heart disease.

Molsidomine may cause a range of adverse reactions, most of which are dose‑related and reversible.

Common Side Effects: - Headache - Dizziness or light‑headedness - Flushing of the skin - Nausea or mild gastrointestinal upset - Transient hypotension - Tachycardia

Serious or Rare Side Effects: - Severe hypotension leading to syncope - Allergic reactions such as rash or urticaria - Rare cases of myocardial infarction - Hepatic enzyme elevation or liver dysfunction

Molsidomine requires careful assessment and monitoring before and during therapy.

Assess cardiovascular status: evaluate blood pressure and heart rate prior to initiation. Avoid concurrent nitrates: co‑administration may cause additive hypotension. Monitor for hypotension: watch for dizziness, fainting, or falls. Use cautiously in hepatic impairment: consider dose adjustment or increased monitoring. Pregnancy and lactation: safety not established; weigh benefits against potential risks. Store at ambient temperature: keep in the original pack, protect from moisture and direct sunlight.

Molsidomine can interact with several drug classes, influencing blood pressure and vascular tone.

Major Interactions (Avoid): - Other nitrates (e.g., nitroglycerin): risk of profound hypotension. - Phosphodiesterase‑5 inhibitors (e.g., sildenafil): additive vasodilatory effect. - Potent antihypertensives (e.g., clonidine): may cause excessive blood pressure drop.

Moderate Interactions (Monitor Closely): - Beta‑blockers: may blunt compensatory tachycardia. - Calcium channel blockers: monitor for combined blood pressure effects. - Diuretics: watch for volume depletion and orthostatic changes.